# Advisor Review - GPT-5-mini

**Role:** Academic advisor checking for fatal errors
**Model:** openai/gpt-5-mini
**Paper:** paper.pdf
**Timestamp:** 2026-02-03T22:45:21.095617
**Route:** OpenRouter + LaTeX
**Tokens:** 14855 in / 1131 out
**Response SHA256:** b5f8109c41b1bd06

---

I reviewed the full LaTeX source carefully, focusing only on the four fatal-error categories you instructed (Data-Design Alignment, Regression Sanity, Completeness, Internal Consistency). I checked every numerical claim and each reported table/figure/result that appears in the source.

Findings: I found no fatal errors.

Notes on what I checked (brief):
- Data-design alignment: The treatment (age-26 dependent-coverage cutoff) is timed within the 2023 natality data; the running variable (mother's age) and sample (ages 22–30) provide observations on both sides of the cutoff. The paper explicitly discusses the discrete age measurement and uses appropriate methods (local-randomization, discrete-RD references). Policy timing claims are consistent with data coverage.
- Regression sanity: Reported coefficients and standard errors in text (e.g., RD estimate 0.027, SE 0.005; private insurance -0.031 SE 0.005; placebo and heterogeneity estimates) are of plausible magnitude for percentage-point outcomes and SEs are not implausible or larger than coefficients by prohibited multiples. No R², SE, or coefficient impossibilities (NaN, Inf, negative SEs, R² > 1) appear in the source text. The paper cites and appears to use robust bias-corrected inference appropriate for RD.
- Completeness: The manuscript does not contain "NA/TBD/TODO/PLACEHOLDER/XXX" tokens; sample sizes are stated (final N = 1,644,832) and sample construction is described. Standard errors and confidence intervals are reported in the main results text and the appendix says covariate-adjusted estimates are reported; figures and tables are referenced. Bibliography and appendices are present.
- Internal consistency: Numbers reported in abstract, main text, and appendix (sample sizes, main point estimates, exclusion counts) are consistent with each other. The paper flags and discusses potential threats (discrete running variable, placebo discontinuities at other ages, small education imbalance) and presents robustness checks. Treatment definition (loss of dependent coverage at age 26) is consistently described across sections.

Given the charge—to catch only FATAL ERRORS that would embarrass the student or waste a journal's time—I find no such errors in this source.

ADVISOR VERDICT: PASS